Filter
2799
Filtered Results: 2799
Text search:
Drug
Resistance
Featured
Recommendations
297
New Publications
751
Language
Document type
No document type
1646
Studies & Reports
409
Guidelines
409
Manuals
115
Strategic & Response Plan
86
Fact sheets
51
Training Material
40
Situation Updates
16
Infographics
13
Online Courses
5
Resource Platforms
4
Videos
3
Brochures
2
Countries / Regions
India
154
Kenya
80
South Africa
77
Western and Central Europe
75
Global
75
Ethiopia
61
Uganda
53
Nepal
48
Eastern Europe
47
Tanzania
46
Africa
46
Zambia
40
Nigeria
39
Liberia
38
Sierra Leone
35
Latin America and the Carribbean
33
Malawi
32
Philippines
31
Myanmar / Burma
30
Ghana
28
Rwanda
27
Bangladesh
27
Cambodia
24
Namibia
24
Asia
24
Lesotho
22
South–East Asia Region
21
Zimbabwe
20
Indonesia
19
Ukraine
19
Russia
19
Senegal
18
Botswana
14
Congo, Democratic Republic of
13
Cameroon
12
Mozambique
12
Colombia
11
West and Central Africa
10
Middle East and North Africa
10
Venezuela
10
Syria
9
East and Southern Africa
9
Burkina Faso
8
Thailand
8
Eswatini/ Swaziland
8
Eastern Europe and Central Asia
8
Albania
8
Pakistan
7
Germany
7
Argentina
7
USA
6
Haiti
6
Tajikistan
6
Guinea
5
Benin
5
Laos
5
Georgia
5
Vietnam
5
Iraq
4
China
4
Sudan
4
Peru
4
Brazil
4
Western Pacific Region
4
Somalia
3
South Sudan
3
Jordan
3
Afghanistan
3
Lebanon
3
Central African Republic
3
North Macedonia
3
El Salvador
3
Sri Lanka
3
Paraguay
3
Bhutan
3
Estonia
3
Iran
3
Uruguay
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Ecuador
2
Libya
2
Madagascar
2
Mexico
2
Yemen
2
Armenia
2
Southern Africa
2
Timor Leste/ East Timor
2
Moldova
2
Gabon
2
Tunisia
2
Guinea-Bissau
1
Niger
1
Turkey
1
Egypt
1
Gambia
1
Switzerland
1
Serbia
1
Honduras
1
Bolivia
1
Greece
1
Angola
1
Guatemala
1
Nicaragua
1
Fiji
1
Italy
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Romania
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
994
Clinical Guidelines
311
Public Health
126
Women & Child Health
80
Key Resources
55
Capacity Building
38
Pharmacy & Technologies
37
Annual Report MEDBOX
1
Toolboxes
TB
502
HIV
347
AMR
327
Mental Health
112
NTDs
96
COVID-19
94
Pharmacy
75
Rapid Response
61
Planetary Health
49
Caregiver
47
NCDs
36
Ebola
33
Global Health Education
32
Refugee
31
Polio
16
Conflict
14
Cholera
13
Health Financing Toolbox
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Le NCPI a été rempli au cours du 1er trimestre 2014 par une équipe technique de 17 personnes responsabilisées en sous-groupes pour les parties A, B et UA. Les réponses aux différentes questions se sont référées à celles de NCPI de 2012 pour permettre une meilleure logique. La responsabilit...
Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended
Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ...
This guideline document lays out the indicators for monitoring the 2016 Political Declaration on ending AIDS. The Global AIDS Monitoring (GAM) process has been often referenced as a benchmark for successful international accountability mechanisms.
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents, and children: recommendations for a public health approach : December 2014 supplement to the 2013 Consolidated guidelines on the use of antiretroviral drugs...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o...
To evaluate the epidemiological evolution of patients with HIV (PtHIV), between 2002 and 2012, in a day-hospital that became an HIV reference centre for south-west Burkina Faso.
This was a retrospective study of PtHIV followed in the Bobo Dioulasso university hospital since 2002. The study was ba...
This document provides an overview of the 7 main messages contained in the World malaria report 2021
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
This paper reviews the effects of vertical responses to COVID-19 on health systems, services, and people’s access to and use of them in LMICs, where historic and ongoing under-investments heighten vulnerability to a multiplicity of health threats. We use the term ‘vertical response’ to describ...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
